Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767595 · ClinicalTrials.gov registry record · NA
ProACT Post-Approval Study
A NA study of Stress Urinary Incontinence, sponsored by Uromedica.
- Recruiting
- Registry status
- NA
- Development phase
- 145
- Enrollment target
- 6
- Study locations
NCT03767595 is a NA study of Stress Urinary Incontinence that is actively recruiting participants, run by Uromedica. The registered enrollment target is 145 participants, roughly in line with the 159-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target. The trial reports 6 study locations across 6 states.
The verdict
NCT03767595, a NA study of Stress Urinary Incontinence, is actively recruiting participants, sponsored by Uromedica.
- RECRUITING
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
- 6
- Study locations
Study Summary
The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after subsequent SUI therapies.
Conditions Studied
Interventions
- DEVICE ProACT Adjustable Continence Therapy for Men
Study Locations (6)
Colorado
- University of Colorado - Denver
Florida
- University of Florida - Gainesville
Georgia
- Emory University - Atlanta
Kansas
- University of Kansas Medical Center - Kansas City
Michigan
- University of Michigan - Ann Arbor
Minnesota
- CentraCare- St. Cloud - Saint Cloud
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2019-02-19 |
| Est. Completion | 2030-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03767595
The ClinicalTrials.gov registry entry for NCT03767595 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 159-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target. The listed sponsor is Uromedica, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which ProACT Adjustable Continence Therapy for Men is the first listed.
NCT03767595 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Colorado, Florida, Georgia.
Frequently Asked Questions
What is clinical trial NCT03767595 about?
NCT03767595 is a clinical study titled "ProACT Post-Approval Study". The ProACT Post Approval Study is a 5-year prospective, open-label, multi-center study designed to evaluate the long-term incidence of urethral stricture and device erosion after ProACT implantation. In addition, the study will evaluate whether treatment with ProACT affects clinical outcomes after s...
What is the current status of trial NCT03767595?
This trial is currently recruiting. It is a NA study. The enrollment target is 145 participants. The study started on 2019-02-19. Estimated completion is 2030-09-01.
What conditions does trial NCT03767595 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence.
What interventions are being tested in trial NCT03767595?
The interventions under investigation include: ProACT Adjustable Continence Therapy for Men (DEVICE).
Who is sponsoring clinical trial NCT03767595?
This trial is sponsored by Uromedica, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03767595 being conducted?
This trial has 6 study locations across Colorado, Florida, Georgia, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
RECRUITING · NA
-
Effect of Peri-Urethral Stimulation on Intra-Urethral Pressure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.